Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study.

Frontiers in oncology(2023)

引用 0|浏览18
暂无评分
摘要
De-escalation of CRT for HPV+ anal cancer may result in decreased acute toxicities and similar cancer outcomes compared to standard CRT.
更多
查看译文
关键词
anal cancer, human papilloma virus, chemoradiation, risk-adjusted therapy, IMRT
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要